RayCare 2024A: A New Era in Oncology Information Systems
The oncology information system RayCare 2024A has been certified to be interoperable with Varian TrueBeam linear accelerators, version 3.0. This milestone is the result of joint testing activities between RaySearch and Varian Medical Systems during 2024.
Image: Varian TrueBeam linear accelerator
In May 2023, RayCare 5B was certified to be interoperable with TrueBeam 3.0, just 17 months after the release of RayCare 5B. The interoperability certificate for 2024A has been issued even before the release of RayCare 2024A, which is scheduled to be finalized in a few weeks.
TrueBeam is Varian’s most prevalent treatment delivery platform, with thousands of installations in radiation therapy clinics worldwide since its launch in 2010. It supports all treatment techniques and capabilities provided by c-arm linacs, including IMRT, VMAT, and electrons with flexible beam energy selection and non-coplanar beam arrangements.
“By achieving clinical interoperability between TrueBeam and RayCare, Varian again shows our commitment to developing, deploying, and maintaining critical interfaces for our fleet to operate seamlessly.” - Agam Sharda, VP of Product & Portfolio Management at Varian
Image: RaySearch logo
“Interoperability with treatment delivery systems is a key feature of RayCare, and it is gratifying to see that the interoperability of the latest version of RayCare with TrueBeam has been achieved in time for the release,” said Johan Löf, founder and CEO of RaySearch.
The Future of Oncology Information Systems
The interoperability of RayCare 2024A with TrueBeam 3.0 marks a significant step forward in the development of oncology information systems. As the healthcare industry continues to evolve, the need for seamless integration between different systems and technologies will only continue to grow.
Image: Oncology information systems
In this new era of oncology information systems, RayCare 2024A is poised to play a critical role in shaping the future of cancer care. With its advanced features and capabilities, RayCare 2024A is set to revolutionize the way oncology information systems are designed and implemented.
Conclusion
The certification of RayCare 2024A to be interoperable with TrueBeam 3.0 is a significant milestone in the development of oncology information systems. As the healthcare industry continues to evolve, the need for seamless integration between different systems and technologies will only continue to grow. RayCare 2024A is poised to play a critical role in shaping the future of cancer care, and its interoperability with TrueBeam 3.0 is a significant step forward in achieving this goal.
Image: Cancer care
